Picture of Jeonjin Bio Co logo

110020 Jeonjin Bio Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
Basic MaterialsHighly SpeculativeMicro CapMomentum Trap

Annual cashflow statement for Jeonjin Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsARS
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-3,399-1,462-3,418-2,108-3,154
Depreciation
Amortisation
Non-Cash Items67630.51,640-629157
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital323-293-972-14.3-2,105
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities-2,161-1,299-2,310-2,385-3,710
Capital Expenditures-314-722-5,837-1,933-2,129
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items538-77.80.8275-2,177
Sale of Fixed Assets
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities224-800-5,836-1,858-4,306
Financing Cash Flow Items-700-172-196-30.9-726
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities6,22192412,90910,629-5,928
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash4,284-1,1704,7606,383-13,971